...
首页> 外文期刊>Cell death & disease. >Oligodendrocyte precursor cells transplantation protects blood–brain barrier in a mouse model of brain ischemia via Wnt/β-catenin signaling
【24h】

Oligodendrocyte precursor cells transplantation protects blood–brain barrier in a mouse model of brain ischemia via Wnt/β-catenin signaling

机译:Oligodendrocyte前体细胞移植通过Wnt /β-catenin信号传导保护脑缺血小鼠模型中的血脑屏障

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Blood-brain barrier damage is a critical pathological feature of ischemic stroke. Oligodendrocyte precursor cells are involved in maintaining blood-brain barrier integrity during the development. However, whether oligodendrocyte precursor cell could sustain blood-brain barrier permeability during ischemic brain injury is unknown. Here, we investigate whether oligodendrocyte precursor cell transplantation protects blood-brain barrier integrity and promotes ischemic stroke recovery. Adult male ICR mice (n?=?68) underwent 90?min transient middle cerebral artery occlusion. After ischemic assault, these mice received stereotactic injection of oligodendrocyte precursor cells (6?×?105). Oligodendrocyte precursor cells transplantation alleviated edema and infarct volume, and promoted neurological recovery after ischemic stroke. Oligodendrocyte precursor cells reduced blood-brain barrier leakage via increasing claudin-5, occludin and β-catenin expression. Administration of β-catenin inhibitor blocked the beneficial effects of oligodendrocyte precursor cells. Wnt7a protein treatment increased β-catenin and claudin-5 expression in endothelial cells after oxygen-glucose deprivation, which was similar to the results of the conditioned medium treatment of oligodendrocyte precursor cells on endothelial cells. We demonstrated that oligodendrocyte precursor cells transplantation protected blood-brain barrier in the acute phase of ischemic stroke via activating Wnt/β-catenin pathway. Our results indicated that oligodendrocyte precursor cells transplantation was a novel approach to the ischemic stroke therapy.
机译:血脑屏障损伤是缺血性卒中的关键病理特征。 oligodendrocyte前体细胞参与在发育过程中保持血脑屏障完整性。然而,在缺血性脑损伤期间,少突胶质细胞前体细胞是否可以持续血脑屏障渗透性未知。在这里,我们研究了寡突胶质细胞前体细胞移植是否保护血脑屏障完整性并促进缺血性卒中恢复。成年男性ICR小鼠(n?=α68)介入90?min瞬时中间脑动脉闭塞。在缺血性攻击后,这些小鼠接受了立体定向注射少突胚细胞前体细胞(6?×105)。 Oligodendrocyte前体细胞移植缓解了水肿和梗塞体积,并在缺血性卒中后促进了神经恢复。 Oligodendrocyte前体细胞通过增加克劳德蛋白-5,occludin和β-catenin表达降低血脑屏障泄漏。 β-catenin抑制剂的给药阻断了少突胶质细胞前体细胞的有益作用。 Wnt7a蛋白处理在氧 - 葡萄糖剥夺后的内皮细胞中增加β-连环蛋白和克劳德蛋白-5表达,其类似于内皮细胞对少突胶质细胞前体细胞的调理介质处理结果。我们证明,通过激活Wnt /β-catenin途径,少突胚细胞前体细胞移植受缺血性卒中急性期的血脑屏障。我们的研究结果表明,少突胶质细胞前体细胞移植是一种新的缺血性卒中疗法的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号